Apolipoprotein A-V (
apoA-V), a liver-synthesized
apolipoprotein discovered in 2001, strongly modulates fasting plasma
triglycerides (TG). Little is reported on the effect of
apoA-V on postprandial plasma TG, an independent predictor for
atherosclerosis. Overexpressing
apoA-V in mice suppresses postprandial TG, but mechanisms focus on increased lipolysis or clearance of remnant particles. Unknown is whether
apoA-V suppresses the absorption of dietary
lipids by the gut. This study examines how
apoA-V deficiency affects the steady-state absorption and lymphatic transport of dietary
lipids in chow-fed mice. Using
apoA-V knockout (KO, n = 8) and wild-type (WT, n = 8) lymph
fistula mice, we analyzed the uptake and lymphatic transport of
lipids during a continuous infusion of an
emulsion containing [(3)H]
triolein and [(14)C]
cholesterol.
ApoA-V KO mice showed a twofold increase in (3)H (P < 0.001) and a threefold increase in (14)C (P < 0.001) transport into the lymph compared with WT. The increased lymphatic transport was accompanied by a twofold reduction (P < 0.05) in mucosal (3)H, suggesting that
apoA-V KO mice more rapidly secreted [(3)H]TG out of the mucosa into the lymph.
ApoA-V KO mice also produced
chylomicrons more rapidly than WT (P < 0.05), as measured by the transit time of [(14)C]
oleic acid from the intestinal lumen to lymph. Interestingly,
apoA-V KO mice produced a steadily increasing number of
chylomicron particles over time, as measured by lymphatic
apoB output. The data suggest that
apoA-V suppresses the production of
chylomicrons, playing a previously unknown role in lipid metabolism that may contribute to the postprandial
hypertriglyceridemia associated with
apoA-V deficiency.